The predictive power of the annual change in BMI with cognitive performance was investigated by a binary logistic regression analysis (backward) using sex, age, BMI 1990, BMI 2000, diastolic blood pressure, diabetes status, and optimal health status as additional predictors. RESULTS: In the last step, the following variables remained in the model: annual change in BMI (quadratic term; Po0.01); ApoE genotype (Po0.05); and optimal health status (Po0.01). CONCLUSION: The association between the extent of weight change and poorer cognitive performance could be either a consequence of cognitive impairment or an early symptom of neurodegenerative decline.
Introduction
Several studies have found that weight change is associated with cognitive performance. [1] [2] [3] [4] [5] [6] These findings emerged from studies with patients suffering from Alzheimer's disease (AD) and with subjects dieting over a certain period. However, the results of the latter are conflicting. Some report that subjects may have reduced reaction times, 1,2 poorer performance in vigilance tests, 2 or poor immediate recall of words. 2 Other investigations found that dieters have in fact a better word recall performance 1 and that dieting has nearly no impact on cognition. 3 Patients with AD lose weight. [4] [5] [6] Surprisingly, there is one report stating that AD patients are also more likely to gain weight than are controls 4 and the mortality rate among the weight gainers was reduced compared with that of the patients losing weight. 7 An increased resting metabolic rate due to an increased proportion of lean body mass might in part explain the weight loss. 8 However, whether weight change is a consequence of AD or whether it is a symptom of AD cannot be established at present.
In the Nun Study subjects, who were losing weight, had an increased risk of becoming dependent on daily routines that may be interpreted as a consequence of frailty and of poorer cognition. 9 Furthermore, Cossonelo et al 10 reported that multiple health problems were positively associated with poor cognitive performance. Studies with animals support the theory that food restriction may have an influence on cognition. For example, in mice hyperphosphorylation of tau protein, a significant step in AD etiology, may be induced by starvation. 11 On the other hand, brain-derived neurotrophic factor, a factor that plays a controlling role in neuroprotection, is increased in the hippocampus and cerebral cortex in rats on a dietary restriction.
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Given these differing findings, it is of interest to study whether weight change influences the cognitive performance of elderly citizens. Therefore, an explorative study was undertaken with a subsample of the Basel Study population.
Subjects and methods
Design and subjects Subjects were taken from the study population of the prospective Basel Study. 13 Its baseline assessment took place in 1960 and there were follow-up examinations in 1965, 1971, 1990 , and 2000. The survey in 1990 was carried out with a mailed questionnaire. All other surveys were carried out at the local centre by trained field workers. The following analysis uses data from both the 1990 and 2000 follow-up examinations. Subjects could be included in the study if complete data sets of the following measurements were available: follow-up 1965: height measurement; follow-up 1990: body weight; follow-up 2000: body weight, blood pressure, diabetes status, apolipoprotein E (ApoE) genotype, and the CERAD-NAB. 14 In all, 531 subjects fulfilled these criteria. Their characteristics are depicted in Table 1 .
Neuropsychological tests
Subject's cognitive abilities were assessed with the CERAD-NAB. 14 Definition of poor cognitive performance Prior to the assignment, the 11 key variables of the CERAD-NAB were normalised and adjusted for age, sex, and education.
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A subject was considered to have a poor cognitive performance if two or more out of the 11 variables were equal to or below À1.5 standard deviation (s.d.) of the normative mean. 22 Subjects with values below À1.5 s.d. are thought to have a mild cognitive impairment, 23, 24 that is, a transitional state between the cognitive changes of normal ageing and AD.
Definition of 'optimal health' Subjects belonged to the optimal healthy population if they had: no current systemic illnesses; no diseases interfering with the administration of CERAD-NAB (eg hearing problems, visual disturbances, etc); no psychiatric problems; no diseases of the central nervous system (CNS); and no diseases or events during life that could negatively impact on CNS activity.
Annual change in body mass index (BMI)
The BMI was based on the height measurements in 1965 and weight measurements in 1990 and 2000. The annual change in BMI was defined as follows:
Time interval between 1990 and 2000 that is, a minus sign means loosing weight and a plus sign means gaining weight over time.
Definition of weight history
Based on the annual change in BMI, the following three categories of weight histories were determined: (1) stable weight: À0.05Zxr0.05 kg/m 2 y; (2) gaining weight:
x40.05 kg/m 2 y; and (3) loosing weight: xoÀ0.05 kg/m 2 y.
ApoE genotype
Leucocytes from venous blood samples were used to isolate DNA. The genotyping was performed by means of PCR techniques as described in detail elsewhere. 25 Based on these results, the subjects were split into ApoE-e4 noncarriers and ApoE-e4 carriers (homo-or heterozygote). This study was approved by the Local Ethics Committee.
Results

Subjects
The sample contained more men. Men differed from women in the following variables: age; diastolic blood pressure; BMI in follow-up 1990; and, therefore, also in the annual change in BMI (ANOVA; all P-values o0.01). The percentage of 75-plus-y-old was 27.5.
Weight history
The three different weight history patterns are recorded in Table 2 . The patterns differed significantly between men and women (Po0.01). More women gained weight compared with men, while more men lost weight compared with women In a separate analysis for the less than 75-y-old, similar numbers were found for gaining (65% women vs 49% men) and loosing weight (13% women vs 22% men). The annual change in BMI differed significantly between the 75-plus-y-old and the younger population (Po0.01). Moreover, the weight history patterns differed significantly between the two age groups (Po0.01).
ApoE genotype and weight change
No differences in the annual change in BMI between ApoE-e4 noncarriers and the ApoE-e4 carriers could be found (P ¼ 0.18).
Poor cognitive performance and weight change Binary logistic regression analysis with backward elimination was performed with poor cognitive performance vs normal cognitive performance as the outcome variable and the following predictor variables: annual change in BMI (linear and quadratic term); sex; age; BMI 1990; BMI 2000; diastolic blood pressure; diabetes status (yes/no); ApoE genotype (e4 carriers vs non-e4 carriers); and optimal health (yes/no). At the last step, the annual change in BMI (quadratic term; Po0.01); ApoE genotype (Po0.05); and optimal health (Po0.01) remained in the model.
For mathematical reason, a quadratic model should always include the linear and the quadratic term. Therefore, a final binary logistic regression analysis was performed with the variables annual change in BMI (linear and quadratic term); ApoE genotype; and optimal health as predictors. Table 3 shows the outcome.
The odds ratio (OR) for having poor cognitive performance between a population experiencing weight change and a population experiencing stable weight status is illustrated in Figure 1 . The greater the change in BMI of the weight changing population, the higher the OR for poor cognitive function.
The ORs for having poor cognitive performance of ApoE-e4 noncarriers vs the ApoE-e4 carriers and of the optimally healthy population vs the nonoptimally healthy is depicted in Table 4 . ApoE-e4 noncarriers and optimally healthy subjects are significantly less likely to have poor cognitive performance.
The OR for having poor cognitive performance of the ApoE-e4 carrier population with weight change compared with ApoE-e4 noncarriers without weight change is exacerbated when their weight change increases. This is outlined in Figure 1 .
Discussion
This explorative study investigated the relationship between the annual change in BMI and cognitive performance in a Weight change and cognition D Brubacher et al free-living nondemented elderly population. A binary logistic regression revealed the following variables as predictors of poor cognitive performance: annual change in BMI (quadratic term), homo-or heterozygote in ApoE-e4, and 'not optimally healthy'. The results of an increased risk of poor cognitive performance for a population with an ApoE-e4 genotype (for a review see Roses et al 27 ) as well as an absence of optimal health 10 is consistent with the literature.
Several studies described a positive association between weight loss and cognitive performance. 1, 2, [4] [5] [6] In contrast, this study demonstrates that for both weight loss and weight gain there is a worsening of cognition. According to our model an OR of 1.5 indicates an annual change in BMI of either À0.5 or þ 0.3 kg/m 2 y, that is, a person weighing 70 kg and measuring 170 cm will have lost 14.5 kg or gained 8.6 kg over a 10-y period.
Owing to osteoporosis or for other orthopaedic reasons height might change significantly during lifetime and therefore the BMI calculations may not be useful. One of the strength of our study is that we had access to the height measurements of the survey in 1965 for all BMI calculations to overcome this problem.
The weight of each individual in the survey population of 1990 was taken from a questionnaire. A concern may be the under-reporting of weight, especially in the obese, which would introduce a bias. A recent paper reported a mean difference of only 1.0 kg between self-reported weight and measured weight in a study sample with elderly people aged between 60 and 79 y. 28 And the strong association of substantial weight change with poor cognitive performance would become even stronger if under-reporting occurred. Furthermore, in a subanalysis (in preparation) of 392 subjects having BMI data from the assessments in 1960, 1965, 1970, 1990 , and 2000 (all weights except for those from 1990 were recorded by field workers), the individual BMI from 1990 exhibited a value that was to be expected by the data of 1960, 1965, 1970 , and 2000. One could argue that the unexpected findings of the present study were due to selection bias since the study population used the survivors of the Basel Study population, which itself was in 1960 a convenient sample of workers and employees of four large chemical and pharmaceutical companies in Basel. Nevertheless, it was shown that the Basel Study population is fairly well representative of Basel citizens and in general of the Swiss working population. 13 Regression analysis ensures that there is no bias in the results due to the unbalanced proportion of gender. However, the gender effect rendered less precise, that is, its confidence interval (CI) is larger than it would be in the balanced case, but the mean estimation is identical.
The association between weight change and cognitive performance could be interpreted either (a) as a consequence of cognitive impairment or (b) as an early symptom of neurodegenerative decline. Weight change could very well be a symptom of less control for appetite. Our study suggests that elderly persons should maintain bodyweight consciously. In keeping AD patients' body weight in balance may prove to be of clinical importance because weight loss is, in fact, associated with higher mortality, 7 and a substantial weight gain in the elderly population may increase the prevalence and severity of cardiovascular risk factors, that is, hypertension, diabetes, and hyperlipidaemia. Odds ratio ¼ Odds ½weight change Odds ½stable weight :
Odds ratio ¼ Odds½weight change þ ApoE À e4 carrier Odds½stable weight þ ApoE À e4 noncarrier : Weight change and cognition D Brubacher et al
